SCHEMBL20434643

SCHEMBL20434643

C=COc1ccc2c(c1)[nH]c1cc(C)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 6/20 0.51
▸ RXFP1 Q9HBX9 2/20 0.41
▸ MAOA P21397 2/20 0.41
▸ PIM3 Q86V86 2/20 0.39
▸ KDM4E B2RXH2 5/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ DYRK1A Q13627 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ DYRK3 O43781 1/20 0.37
▸ CCNT1 O60563 1/20 0.37
▸ CCNB2 O95067 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ ADRA2C P18825 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20438860 0.85 KDM4E (0.52) RXFP1MAOAPIM3KDM4EALDH1A1
SCHEMBL6009651 0.79 KDM4E (0.59) KIF11RXFP1MAOAPIM3KDM4E
SCHEMBL4256780 0.78 KIF11 (0.78) KIF11RXFP1PIM3KDM4EALDH1A1
SCHEMBL29518339 0.78 KIF11 (0.78) KIF11RXFP1PIM3KDM4EALDH1A1
SCHEMBL20434634 0.77 KIF11 (0.51) KIF11RXFP1MAOAPIM3KDM4E
SCHEMBL20434641 0.75 KIF11 (0.53) KIF11MAOAKDM4EALDH1A1DYRK1A
SCHEMBL13828017 0.73 KIF11 (0.72) KIF11RXFP1PIM3ACHEMAPT
SCHEMBL10061536 0.73 CYP1A2 (0.39) MAOAKDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL20434631 0.72 KIF11 (0.50) KIF11RXFP1MAOAKDM4EALDH1A1
SCHEMBL194091 0.71 ACHE (0.48) ALDH1A1CYP3A4HPGDACHESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180215712-A1 SMALL MOLECULE ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF GEORGETOWN UNIVERSITY (US) 2018-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180215712-A1 SMALL MOLECULE ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF AR, KLK3, BRDT KIF11 2408/4885RXFP1 1281/4885MAOA 3180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback